Sunesis Pharmaceuticals,Inc。(SNSS) 临时首席执行官 Dayton Misfeldt 于 2019年 第二季度业绩 - 收益电话会议记录

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Sunesis Pharmaceuticals,Inc。(纳斯达克股票代码:[SNSS])2019年第二季度收益电话会议2019年8月7日美国东部时间下午4:30 公司参与者 Willie Quinn - Chief Financial Officer & Senior Vice President, Corporate Development Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer Par Hyare - Senior Vice President Commercial Deepali Suri - Vice President, Clinical Operations Willie Quinn - 首席财务官兼企业发...